1. Home
  2. NRDS vs CDNA Comparison

NRDS vs CDNA Comparison

Compare NRDS & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NerdWallet Inc.

NRDS

NerdWallet Inc.

HOLD

Current Price

$10.65

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$17.93

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRDS
CDNA
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
NRDS
CDNA
Price
$10.65
$17.93
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$14.33
$27.33
AVG Volume (30 Days)
829.9K
497.6K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
68.42
N/A
EPS
0.64
N/A
Revenue
$836,600,000.00
$48,324,000.00
Revenue This Year
$10.13
$16.01
Revenue Next Year
$7.11
$11.31
P/E Ratio
$16.39
N/A
Revenue Growth
21.67
18.93
52 Week Low
$7.86
$10.96
52 Week High
$16.24
$21.49

Technical Indicators

Market Signals
Indicator
NRDS
CDNA
Relative Strength Index (RSI) 53.19 49.76
Support Level $10.23 $16.63
Resistance Level $10.70 $20.94
Average True Range (ATR) 0.36 0.87
MACD 0.08 0.13
Stochastic Oscillator 71.30 58.12

Price Performance

Historical Comparison
NRDS
CDNA

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: